12:00 AM
Nov 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

Agenix, Tyrian deal

Agenix received exclusive, worldwide, royalty-free rights to Tyrian's DianostIQ rapid point-of-care technology for human health applications. As part of the deal,...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >